The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The ...

Amid rumors about Israeli PM Benjamin Netanyahu's prostate surgery, medical experts raise key questions about the procedure's ...

Most important note is- surgeries for benign enlargement removes only the center part of the prostate to clear the ...

Thousands of men in the UK with advanced hormone-sensitive prostate cancer could soon be eligible for an oral therapy – Accord Healthcare's Orgovyx – that can be taken at home rather than ...

Evan Y. Yu, MD, discusses how individualized first-line systemic therapy selection for metastatic hormone-sensitive prostate ...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT ... patients with metastatic hormone-sensitive prostate cancer (mHSPC) and will be ...

This advanced imaging technology plays a critical role in redefining how prostate cancer is staged. PSMA-PET imaging uses tiny amounts of radioactive “tracers,” called radiotracers, that binds to ...

The problem with prostate cancer is that there really are not any obvious symptoms. Men can present getting up at night to urinate, going frequently during the daytime; those really are all ...

Evan Y. Yu, MD, discusses how systemic therapy options for newly diagnosed metastatic hormone-sensitive prostate cancer ...

Prostaid Calgary, a support group for men, spouses, and caregivers affected by prostate cancer in the greater Calgary area, ...

Cite this: The Role of Hormonal Therapy in the Management of Hormonal-Receptor-Positive Breast Cancer With Co-Expression of HER2 - Medscape - Sep 01, 2008. The article is based primarily on a ...